3 Takeaways from the FDA Oligo Guidance You Need to Know Blog 3 Takeaways from the FDA Oligo Guidance You Need to Know In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…CertaraSeptember 23, 2022
Pinnacle 21 Data Exchange: Transforming External Vendor Data Management On-Demand Webinar Pinnacle 21 Data Exchange: Transforming External Vendor Data Management The volume and complexity of clinical data are growing at a faster pace than the…CertaraSeptember 19, 2022
Accelerating Pediatric Drug Development with Biosimulation and Regulatory Science Fact Sheet Accelerating Pediatric Drug Development with Biosimulation and Regulatory Science CertaraSeptember 13, 2022
Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them Press Coverage Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them “Quantitative decision-making with data rather than empirical thinking" - Certara's Modeling & Simulation technology contributes…CertaraSeptember 13, 2022
Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection On-Demand Webinar Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection For the past two years, the biotech sector saw a surge of venture funding and…CertaraAugust 30, 2022
3 Major Implications of New European Clinical Trial Regulations Blog 3 Major Implications of New European Clinical Trial Regulations Have you heard the buzz around the new European Union Clinical Trial Regulations (EU-CTR) for…CertaraAugust 25, 2022
Mind-blowing applications of QSP in drug development: Part 2 Blog Mind-blowing applications of QSP in drug development: Part 2 Part 2 of this blog series dives further into the June 2022 podcast with R&D…CertaraAugust 15, 2022
Why are Human Radiolabeled Mass-balance Studies Important in Clinical Pharmacology & Drug Development? Blog Why are Human Radiolabeled Mass-balance Studies Important in Clinical Pharmacology & Drug Development? Human mass-balance studies are also called “C-14 studies” or “Absorption, Metabolism, and Excretion (AME) studies.”…CertaraAugust 5, 2022
Mind-blowing applications of QSP in drug development: Part 1 Blog Mind-blowing applications of QSP in drug development: Part 1 R&D World editors, Paul Heney and Aimee Kalnoskas, have their minds blown — multiple times!…CertaraAugust 4, 2022
How Pharmaceutical Companies Can Engage Payers Digitally Blog How Pharmaceutical Companies Can Engage Payers Digitally Pharmaceutical companies should seize opportunities to digitally engage with payers globally using both face-to-face and…CertaraJuly 29, 2022